# Effect of Low-dose Pregabalin Retard (82.5 mg) Versus Standard-dose Pregabalin Retard (165 mg) on Postoperative Pain and Opioid Consumption After Elective Laparoscopic Abdominal Surgery

> **NCT07456761** · NA · NOT_YET_RECRUITING · sponsor: **South Egypt Cancer Institute** · enrollment: 80 (estimated)

## Conditions studied

- Laparoscopic Abdominal Surgeries

## Interventions

- **DRUG:** Pregabalin retard 82.5 mg
- **DRUG:** Pregabalin retard 165 mg

## Key facts

- **NCT ID:** NCT07456761
- **Lead sponsor:** South Egypt Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-11
- **Final completion:** 2026-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07456761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07456761, "Effect of Low-dose Pregabalin Retard (82.5 mg) Versus Standard-dose Pregabalin Retard (165 mg) on Postoperative Pain and Opioid Consumption After Elective Laparoscopic Abdominal Surgery". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT07456761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*